Penn Medicine

Penn Medicine This is the official account for the University of Pennsylvania Health System.

Penn Medicine is dedicated to high-quality patient care and service, advancing medical science through research, and educating the next generation of leaders in medicine.

06/10/2026

When we founded the nation's first hospital, the goal was simple: push the boundaries of medicine to better serve humanity. That same spirit drives our laboratories today.

Thought-controlled prosthetics could soon restore independence for patients living with paralysis. Dr. Iahn Cajigas is leading groundbreaking research into how these devices communicate with the mind, a vital step forward that could completely revolutionize our understanding of the human brain.

For Dr. Dovie Watson and Dr. Katie Dalke, providing inclusive healthcare is deeply personal. Growing up, both experience...
06/09/2026

For Dr. Dovie Watson and Dr. Katie Dalke, providing inclusive healthcare is deeply personal. Growing up, both experienced firsthand what it feels like when the medical establishment doesn't fully see or respect you—whether navigating care as a Black, bisexual patient or managing an intersex condition from a young age.

Now, both physicians are stepping into leadership roles within the Penn Medicine Program for LGBTQ+ Health. They are using their own journeys to ensure patients never have to code-switch, face judgment, or compromise on getting the care they deserve.

Alongside Medical Director Dr. Kevin Kline, they are expanding the program's reach across Philadelphia, focusing on community-led research, clinical excellence, and policy change.

06/04/2026

In 2017, Penn Medicine made history by pioneering the world’s first U.S. Food and Drug Administration-approved CAR T-cell therapy for blood cancer. Now, our researchers are using that same cellular breakthrough to revolutionize transplant medicine.

Published in The New England Journal of Medicine, a pioneering clinical trial led by Dr. Ali Naji has successfully enabled "highly sensitized" kidney disease patients to receive previously improbable transplants. By utilizing dual CAR T-cell therapy to "reset" the immune system, the team cleared away the harmful antibodies that had blocked donor matches for years.

For Philadelphia resident Andrew Boyd, who had a near-0% chance of finding a match, this innovation meant another chance at life.

From inventing cellular immunotherapy to redefining the boundaries of organ transplantation, we continue to lead. Because being first then means putting patients first now.

🎥: CBS Philadelphia

Address

Philadelphia, PA

Telephone

+12156627366

Website

Alerts

Be the first to know and let us send you an email when Penn Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Penn Medicine:

Shortcuts

Featured

Share

Category